CCKAR anticorps (AA 228-257)

N° du produit ABIN1881149

Détail du produit anti-CCKAR anticorps

Antigène: CCKAR (Cholecystokinin A Receptor (CCKAR))

Épitope: AA 228-257

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CCKAR est non-conjugé

Application: Western Blotting (WB)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This CCKAR antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 228-257 amino acids from the Central region of human CCKAR.

Clone: RB40248

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-CCKAR (ABIN1881149)

Cong, Pricolo, Biancani, Behar: "Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle." dans: American journal of physiology. Gastrointestinal and liver physiology, Vol. 299, Issue 3, pp. G742-50, (2010) (PubMed).

Park, Rew, Lee, Ki, Lee, Cheo, Kim, Noh, Joo, Kim, Choi: "Association of CCK(1) Receptor Gene Polymorphisms and Irritable Bowel Syndrome in Korean." dans: Journal of neurogastroenterology and motility, Vol. 16, Issue 1, pp. 71-6, (2010) (PubMed).

Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." dans: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

Ruaño, Thompson, Kane, Pullinger, Windemuth, Seip, Kocherla, Holford, Wu: "Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?" dans: Pharmacogenomics, Vol. 11, Issue 7, pp. 959-71, (2010) (PubMed).

Détails sur CCKAR

Antigène: CCKAR (Cholecystokinin A Receptor (CCKAR))

Autre désignation: CCKAR (CCKAR Produits)

Synonymes: anticorps CCK-XL, anticorps cck-a, anticorps cck1-r, anticorps cckar-A, anticorps cckbr, anticorps cckra, anticorps CCKAR, anticorps CCK-A, anticorps CCK1-R, anticorps CCKRA, anticorps AW106902, anticorps Cck-ar, anticorps CCK-AR, anticorps cholecystokinin A receptor, anticorps cholecystokinin A receptor L homeolog, anticorps CCKAR, anticorps cckar.L, anticorps Cckar

Sujet: This gene encodes a G-protein coupled receptor that binds non-sulfated members of the cholecystokinin (CCK) family of peptide hormones. This receptor is a major physiologic mediator of pancreatic enzyme secretion and smooth muscle contraction of the gallbladder and stomach. In the central and peripheral nervous system this receptor regulates satiety and the release of beta-endorphin and dopamine.

Poids moléculaire: 47841

NCBI Accession: NP_000721

UniProt: P32238

Pathways: Positive Regulation of Peptide Hormone Secretion, Hormone Transport, Feeding Behaviour